Home
/
Glossary
/
Kidney Tissue Distribution
General Biopharmaceutical Concepts

Kidney Tissue Distribution

Kidney tissue distribution evaluates the extent and pattern of therapeutic compound localisation within renal tissues following administration.

Kidney tissue distribution describes pharmaceutical accumulation in renal compartments potentially causing nephrotoxicity. Glomerular filtration concentrates drugs in ultrafiltrate. Proximal tubular reabsorption concentrates lipophilic drugs. Organic anion transporters actively accumulate anionic drugs. Acute tubular necrosis results from excessive concentration.

Nephroprotective strategies including hydration reduce concentration. Therapeutic drug monitoring guides dose adjustments. Biomarkers including kidney injury molecules detect early toxicity. Regulatory submissions address nephrotoxicity risk. Post-approval surveillance identifies unexpected renal effects.

📘 Explore the Glossary

✓ 903 Definitions

✓ 18 Categories

✓ Updated Weekly

Continue Exploring

Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.

Browse Glossary →
WhatsApp